Correlation Between Spyre Therapeutics and 00108WAP5

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and 00108WAP5 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and 00108WAP5 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and AEP 47 15 MAY 32, you can compare the effects of market volatilities on Spyre Therapeutics and 00108WAP5 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of 00108WAP5. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and 00108WAP5.

Diversification Opportunities for Spyre Therapeutics and 00108WAP5

-0.39

Correlation Coefficient

Spyre Therapeutics  00108WAP5

Very good diversification

The 3 months correlation between Spyre and 00108WAP5 is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and AEP 47 15 MAY 32 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AEP 47 15 and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with 00108WAP5. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AEP 47 15 has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and 00108WAP5 go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and 00108WAP5

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the 00108WAP5. In addition to that, Spyre Therapeutics is 8.14 times more volatile than AEP 47 15 MAY 32. It trades about -0.1 of its total potential returns per unit of risk. AEP 47 15 MAY 32 is currently generating about 0.03 per unit of volatility. If you would invest  9,569  in AEP 47 15 MAY 32 on December 23, 2024 and sell it today you would earn a total of  83.00  from holding AEP 47 15 MAY 32 or generate 0.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	96.83%
Values	Daily Returns

Spyre Therapeutics  vs.  AEP 47 15 MAY 32

Spyre Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

AEP 47 15

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in AEP 47 15 MAY 32 are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 00108WAP5 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Spyre Therapeutics and 00108WAP5

The main advantage of trading using opposite Spyre Therapeutics and 00108WAP5 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, 00108WAP5 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 00108WAP5 will offset losses from the drop in 00108WAP5's long position.

The idea behind Spyre Therapeutics and AEP 47 15 MAY 32 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.